TAYD · Taylor Devices, Inc.
5 customers — 45% of revenue (2026)
“Sales to five customers accounted for approximately 45% (11%, 11%, 10%, 8% and 5%, respectively) of our net sales for 2026.”
One customer — 11% of revenue (2026)
“Sales to five customers accounted for approximately 45% (11%, 11%, 10%, 8% and 5%, respectively) of our net sales for 2026.”
One customer — 11% of revenue (2026)
“Sales to five customers accounted for approximately 45% (11%, 11%, 10%, 8% and 5%, respectively) of our net sales for 2026.”
One customer — 10% of revenue (2026)
“Sales to five customers accounted for approximately 45% (11%, 11%, 10%, 8% and 5%, respectively) of our net sales for 2026.”
One customer — 8% of revenue (2026)
“Sales to five customers accounted for approximately 45% (11%, 11%, 10%, 8% and 5%, respectively) of our net sales for 2026.”
One customer — 5% of revenue (2026)
“Sales to five customers accounted for approximately 45% (11%, 11%, 10%, 8% and 5%, respectively) of our net sales for 2026.”
3 customers — 42% of revenue (2025)
“Sales to three customers accounted for approximately 42% (21%, 15% and 6%, respectively) of our net sales for 2025.”
One customer — 21% of revenue (2025)
“Sales to three customers accounted for approximately 42% (21%, 15% and 6%, respectively) of our net sales for 2025.”
One customer — 15% of revenue (2025)
“Sales to three customers accounted for approximately 42% (21%, 15% and 6%, respectively) of our net sales for 2025.”
One customer — 6% of revenue (2025)
“Sales to three customers accounted for approximately 42% (21%, 15% and 6%, respectively) of our net sales for 2025.”
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-04-28 | CAREY ROBERT MICHAEL |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.60, inclusive. The reporting person undertakes to provide to Taylor Devices, Inc., any security holder of Taylor Devices, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
Common Stock
|
1,555 |
| 2026-04-28 | CAREY ROBERT MICHAEL |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.30, inclusive. The reporting person undertakes to provide to Taylor Devices, Inc., any security holder of Taylor Devices, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. |
Common Stock
|
3,445 |
| 2026-04-18 | Sopko Timothy John |
Director, Chief Executive Officer |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2026-04-18 | Burgess John |
Director |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2026-04-18 | Armenat Fritz Eric |
Director |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2026-04-18 | Heary Paul Murray |
Chief Financial Officer |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2026-04-18 | CAREY ROBERT MICHAEL |
Director |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2026-04-13 | Burgess John |
Director |
Tax↓
|
Common Stock
|
1,574 |
| 2026-04-13 | Burgess John |
Director |
Convert↓
|
Stock Option (Right to Buy)
|
5,000 |
| 2026-04-13 | Burgess John |
Director |
Convert↑
|
Common Stock
|
5,000 |
| 2026-01-23 | Armenat Fritz Eric |
Director |
Sell↓
|
Common Stock
|
528 |
| 2026-01-23 | Armenat Fritz Eric |
Director |
Sell↓
|
Common Stock
|
700 |
| 2026-01-23 | Armenat Fritz Eric |
Director |
Sell↓
|
Common Stock
|
300 |
| 2026-01-22 | Armenat Fritz Eric |
Director |
Sell↓
|
Common Stock
|
2,800 |
| 2026-01-21 | Armenat Fritz Eric |
Director |
Convert↑
|
Common Stock
|
5,000 |
| 2026-01-21 | Armenat Fritz Eric |
Director |
Tax↓
|
Common Stock
|
672 |
| 2026-01-21 | Armenat Fritz Eric |
Director |
Convert↓
|
Stock Option (Right to Buy)
|
5,000 |
| 2026-01-14 | Armenat Fritz Eric |
Director |
Sell↓
|
Common Stock
|
300 |
| 2026-01-14 | Armenat Fritz Eric |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.65 to $73.57. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,820 |
| 2026-01-09 | Armenat Fritz Eric |
Director |
Tax↓
|
Common Stock
|
880 |
| 2026-01-09 | Armenat Fritz Eric |
Director |
Convert↓
|
Stock Option (Right to Buy)
|
5,000 |
| 2026-01-09 | Armenat Fritz Eric |
Director |
Convert↑
|
Common Stock
|
5,000 |
| 2025-04-23 | Sopko Timothy John |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
11 |
| 2025-04-23 | Sopko Timothy John |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
290 |
| 2025-04-23 | Sopko Timothy John |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
699 |
| 2025-04-18 | Sopko Timothy John |
Director, Chief Executive Officer |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2025-04-18 | Burgess John |
Director |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2025-04-18 | CAREY ROBERT MICHAEL |
Director |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2025-04-18 | Heary Paul Murray |
Chief Financial Officer |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2025-04-18 | Armenat Fritz Eric |
Director |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2025-04-18 | Klembczyk Alan Raymond |
Director, President |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2025-04-14 | Burgess John |
Director |
Convert↑
|
Common Stock
|
5,000 |
| 2025-04-14 | Burgess John |
Director |
Convert↓
|
Stock Option (Right to Buy)
|
5,000 |
| 2025-01-13 | Sopko Timothy John |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
1,000 |
| 2024-10-28 | CAREY ROBERT MICHAEL |
Director |
Convert↑
|
Common Stock
|
5,000 |
| 2024-10-28 | CAREY ROBERT MICHAEL |
Director |
Convert↓
|
Stock Option (Right to Buy)
|
5,000 |
| 2024-10-28 | CAREY ROBERT MICHAEL |
Director |
Tax↓
|
Common Stock
|
2,279 |
| 2024-10-28 | CAREY ROBERT MICHAEL |
Director |
Convert↑
|
Common Stock
|
5,000 |
| 2024-10-28 | CAREY ROBERT MICHAEL |
Director |
Convert↓
|
Stock Option (Right to Buy)
|
5,000 |
| 2024-09-18 | Klembczyk Alan Raymond |
Director, President |
Convert↑
|
Common Stock
|
3,000 |
| 2024-09-18 | Klembczyk Alan Raymond |
Director, President |
Convert↓
|
Stock Option (Right to Buy)
|
3,000 |
| 2024-09-18 | Klembczyk Alan Raymond |
Director, President |
Convert↑
|
Common Stock
|
5,000 |
| 2024-09-18 | Klembczyk Alan Raymond |
Director, President |
Convert↓
|
Stock Option (Right to Buy)
|
5,000 |
| 2024-04-18 | Armenat Fritz Eric |
Director |
Award↑
|
Stock Option (Right to Buy)
|
7,000 |
| 2024-04-18 | Heary Paul Murray |
Chief Financial Officer |
Award↑
|
Stock Option (Right to Buy)
|
7,000 |
| 2024-04-18 | CAREY ROBERT MICHAEL |
Director |
Award↑
|
Stock Option (Right to Buy)
|
7,000 |
| 2024-04-18 | Burgess John |
Director |
Award↓
|
Stock Option (Right to Buy)
|
7,000 |
| 2024-04-18 | Sopko Timothy John |
Director, Chief Executive Officer |
Award↑
|
Stock Option (Right to Buy)
|
7,000 |
| 2024-04-18 | Klembczyk Alan Raymond |
Director, President |
Award↑
|
Stock Option (Right to Buy)
|
7,000 |
| 2024-04-08 | Burgess John |
Director |
Convert↑
|
Common Stock
|
5,000 |